NICE widens eczema treatment options

NICE has recommended the use of alitretinoin as a treatment option for adults with severe chronic hand eczema who have not responded to treatment with topical corticosteroids.

The guidance, published last week, states that alitretinoin treatment should be stopped as soon as an adequate response has been achieved.

The treatment should not be continued for longer than 24 weeks if no improvement in the condition has been seen.

Dr Stephen Kownacki, chairman of the Primary Care Dermatology Society and a GP in Northampton, welcomed the decision by NICE.

 ‘GPs can now refer those patients who have run out of treatment options to be considered for alitretinoin,' he said.

sanjay.tanday@haymarket.com

 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus